BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai G, Ma X, Zou W, Huang Y, Zhang J, Wang D, Chen B. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis. Gene 2014;546:117-23. [PMID: 23933413 DOI: 10.1016/j.gene.2013.07.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Li QK, Shah P, Tian Y, Hu Y, Roden RBS, Zhang H, Chan DW. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors. Clin Proteomics 2017;14:16. [PMID: 28491011 DOI: 10.1186/s12014-017-9152-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
2 Ghazy AA, El-Etreby NM. Relevance of HLA-DP/DQ and ICAM-1 SNPs among Ovarian Cancer Patients. Front Immunol 2016;7:202. [PMID: 27252704 DOI: 10.3389/fimmu.2016.00202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Koizume S, Miyagi Y. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply. Int J Mol Sci 2017;18:E809. [PMID: 28417928 DOI: 10.3390/ijms18040809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Elsheredy AG, Almaeen AH, Ghazy AA, Helaly GF, Amer I, Ghazy HA, Haydara T. Impact of Interleukin 28B and ICAM-1 Genetic Polymorphisms on Response to Direct Antiviral Treatment Among HCV Infected Patients. Endocr Metab Immune Disord Drug Targets 2020;20:1328-35. [PMID: 32368983 DOI: 10.2174/1871530320666200505113619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang X, Huang J, Bai J, Lu W, Zhang M, Mei H. Association of Polymorphisms in Intercellular Adhesion Molecule 1 (ICAM-1) Gene with Cancer Susceptibility: A Meta-Analysis of 14 Case-Control Studies. Med Sci Monit 2016;22:569-79. [PMID: 26897511 DOI: 10.12659/msm.895811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lu ZH, Gu XJ, Shi KZ, Li X, Chen DD, Chen L. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer. J Formos Med Assoc 2016;115:31-7. [PMID: 25659662 DOI: 10.1016/j.jfma.2015.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Wang S, Yin C, Zhang Y, Zhang L, Tao L, Liang W, Pang L, Fu R, Ding Y, Li F, Jia W. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray. Biomed Res Int 2019;2019:2867372. [PMID: 31312656 DOI: 10.1155/2019/2867372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Assis J, Pereira C, Nogueira A, Pereira D, Carreira R, Medeiros R. Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer Treat Rev 2017;61:35-52. [PMID: 29100168 DOI: 10.1016/j.ctrv.2017.10.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]